We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$940M
AUM Growth
+$184M
Cap. Flow
+$188M
Cap. Flow %
19.99%
Top 10 Hldgs %
24.33%
Holding
2,521
New
978
Increased
249
Reduced
232
Closed
1,038

Sector Composition

Rank Sector Weight
1 Financials 19.86%
2 Technology 12.19%
3 Consumer Discretionary 9.1%
4 Healthcare 8.84%
5 Industrials 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCSA icon
1376
Processa Pharmaceuticals
PCSA
$8.78M
$7K ﹤0.01%
+26
New +$10.5K
SABS icon
1377
SAB Biotherapeutics
SABS
$343M
$7K ﹤0.01%
+1,501
New +$9.49K
SCNX
1378
Scienture Holdings
SCNX
$15.2M
$7K ﹤0.01%
+1,674
New +$9.61K
BTCY
1379
DELISTED
Biotricity, Inc. Common Stock
BTCY
$7K ﹤0.01%
+2,529
New +$10.4K
VQS
1380
DELISTED
VIQ SOLUTIONS INC
VQS
$7K ﹤0.01%
+18,234
New +$6.25K
VYNT
1381
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$7K ﹤0.01%
12,521
+953
+8% +$758
BBAI.WS icon
1382
BigBear.ai Holdings Warrant
BBAI.WS
$41.9M
$6K ﹤0.01%
+23,671
New +$6.09K
KTTA icon
1383
Pasithea Therapeutics
KTTA
$16.5M
$6K ﹤0.01%
743
-804
-52% -$9.09K
LGHL
1384
Lion Group Holding
LGHL
$696K
0
SLDPW icon
1385
Solid Power Inc Warrant
SLDPW
$10.9M
$6K ﹤0.01%
+12,518
New +$6.74K
SYRE icon
1386
Spyre Therapeutics
SYRE
$9.06B
$6K ﹤0.01%
+772
New +$8.47K
XRTX
1387
XORTX Therapeutics
XRTX
$3.72M
$6K ﹤0.01%
+32
New +$8.04K
YCBD icon
1388
cbdMD
YCBD
$6.19M
$6K ﹤0.01%
87
-144
-62% -$13.3K
NEUE
1389
DELISTED
NeueHealth
NEUE
$6K ﹤0.01%
335
-798
-70% -$41.1K
AMZE
1390
Amaze Holdings
AMZE
$1.49M
$6K ﹤0.01%
+68
New +$11.7K
NTBL
1391
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$6K ﹤0.01%
1,069
-414
-28% -$2.22K
POL.WS
1392
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$6K ﹤0.01%
+65,018
New +$6.26K
AREB
1393
DELISTED
American Rebel
AREB
0
CDIOW icon
1394
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$908K
$5K ﹤0.01%
+15,469
New +$3.63K
BNKK
1395
Bonk Inc
BNKK
$8.48M
$5K ﹤0.01%
303
-66
-18% -$1.33K
AWH
1396
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$5K ﹤0.01%
980
-297
-23% -$2.02K
AAU
1397
DELISTED
Almaden Minerals Ltd
AAU
$5K ﹤0.01%
+25,629
New +$5.64K
MBSC.WS
1398
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$5K ﹤0.01%
+12,466
New +$4.82K
IDEX
1399
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$5K ﹤0.01%
+357
New +$6.78K
NYMX
1400
DELISTED
Nymox Pharmaceutical Corp
NYMX
$5K ﹤0.01%
13,324
-6,322
-32% -$2.57K

Similar funds

Virtu Financial's Q1 2023 Portfolio in Review

As of Q1 2023, Virtu Financial held 2,521 positions worth $940M, up 24% from $756M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Virtu Financial deployed $188M of net new capital in Q1 2023, opening 978 new positions and adding to 249 existing holdings. Its largest new stake was Cigna: 35,273 shares worth $9.01M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $40.1M trimmed.

  • Virtu Financial's largest Q1 2023 buy was Cigna: 35,273 shares worth $9.01M.
  • Virtu Financial added most to Yamana Gold, Inc. in Q1 2023, an estimated $50.8M increase.
  • Virtu Financial's biggest Q1 2023 reduction was Berkshire Hathaway Class B, cutting an estimated $40.1M.
  • Virtu Financial fully exited Eli Lilly in Q1 2023, selling an estimated $5.77M.
  • Virtu Financial's ten largest holdings make up 24% of its $940M portfolio in Q1 2023.
  • Virtu Financial opened 978 new positions and closed 1,038 in Q1 2023.
  • Virtu Financial's portfolio value rose 24% quarter-over-quarter to $940M.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.